The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Xomolix 2.5 mg/ml solution for injection



Kyowa Kirin Holdings B.V.PA2288/003/002

Main Information

Trade NameXomolix 2.5 mg/ml solution for injection
Active SubstancesDroperidol
Dosage FormSolution for injection
Licence HolderKyowa Kirin Holdings B.V.
Licence NumberPA2288/003/002

Group Information

ATC CodeN05AD Butyrophenone derivatives
N05AD08 droperidol

Status

License statusAuthorised
Licence Issued29/02/2008
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back